Patent ID: 6833349
Filing Date: 2004-12-21
Classification: A61K,A61P,C07K

Abstract:
A method of treating psoriasis in a mammal comprising administering a VEGF antagonist to the mammal wherein the VEGF antagonist is a fusion protein selected from the group consisting ofacetylated Flt-1(1-3)-Fc, Flt-1(1-3Râ†’N)-Fc, Flt-1(1-3&Dgr;B)-Fc, Flt-1(2-3&Dgr;B)-Fc, Flt-1(2-3)-Fc, Flt-1D2-VEGFR3D3-Fc&Dgr;C1(a), Flt-1D2-Flk-1D3-Fc&Dgr;C1(a), and VEGFR1R2-Fc&Dgr;C1(a), such that psoriasis is treated.